HSDT Solana Company Class A Common Stock (DE)

15 min delay
Today's News Sentiment
Loading...
Upcoming Earnings
Loading...
HSDT Fundamental Data
Loading...
Similar Companies
Loading...
HSDT Options Chain
Put/Call Ratio
-
-
Expected Move
-
-
Max Pain
-
-
ATM Call Break-even
-
-
ATM Put Break-even
-
-
Loading options…
CALLS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
PUTS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
HSDT Insider Transactions
Loading insider data…
HSDT News
Date Headline Sentiment
Shares of crypto-linked companies are trading lower as Bitcoin sells off from its recent rally, possibly after Federal Reserve Chairman Warsh's comments on inflation and prices raised rate-hike concerns. The asset is also under pressure after Treasury Secretary Bessent's letter suggested the Treasury exchanged existing Exchange Stabilization Fund foreign-currency assets for Yen, which contributed to a spike in the dollar value.
96.52%
Shares of crypto-linked stocks are trading higher as Bitcoin's price rises above $80,000 as the digital token extends its rally.
93.74%
Shares of crypto-linked companies are trading higher amid continued Bitcoin price momentum after multiple catalysts, including CFTC Chair Selig recently saying the commission will use its authority to establish a regulatory framework for crypto markets even without Clarity Act passage Also, prediction markets show expectations for Clarity Act becoming law by spring 2027 have risen to 42%, almost doubling from earlier this month.
95.37%
Shares of crypto-linked companies are trading higher amid continued  Bitcoin price momentum after President Trump recently urged Congress to pass the Clarity Act and said the CFTC is working to bring Hyperliquid to the U.S. Investors may be seeing a renewed appetite for high-risk assets after the Treasury Department expanded its debt repurchase program.
93.8%
B. Riley Securities Maintains Buy on Solana, Lowers Price Target to $2.5
67.61%
Full Transcript: Helius Medical Tech Q2 2026 Earnings Call
88.07%
Helius Medical Tech Q2 EPS $(0.38) Misses $(0.07) Estimate, Sales $2.526M Miss $3.600M Estimate
52.2%